middle.news
Avecho Accelerates Phase III CBD Trial with New Sites and Manufacturing Milestone
4:21pm on Thursday 30th of January, 2025 AEDT
•
Biotechnology
Read Story
Avecho Accelerates Phase III CBD Trial with New Sites and Manufacturing Milestone
4:21pm on Thursday 30th of January, 2025 AEDT
Key Points
Phase III trial dosing underway with 70 participants enrolled
Inclusion criteria broadened and two new trial sites added to accelerate recruitment
Interim analysis expected in 2025, a pivotal milestone for Avecho
Completed 11 tonnes of Vital-ET manufacturing for Ashland in 2024
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Avecho Biotechnology (ASX:AVE)
OPEN ARTICLE